Oxygen and xenobiotic reductase activities of cytochrome P450.
暂无分享,去创建一个
[1] R. Nakagawa,et al. Mutagenic/carcinogenic agents in indoor pollutants; the dinitropyrenes generated by kerosene heaters and fuel gas and liquefied petroleum gas burners. , 1985, Mutation research.
[2] R. S. Beyer,et al. Cytochromes P-450 and the activation and inactivation of mutagens and carcinogens. , 1986, Basic life sciences.
[3] B. Ames,et al. Mutagenicity of quinones: pathways of metabolic activation and detoxification. , 1984, Proceedings of the National Academy of Sciences of the United States of America.
[4] M. W. Anders,et al. Metabolism of carbon tetrachloride to phosgene. , 1980, Life sciences.
[5] E. Janzen,et al. Spin trapping of free radical metabolites of carbon tetrachloride in vitro and in vivo: effect of acute ethanol administration. , 1992, Toxicology and applied pharmacology.
[6] D. Fitz,et al. Atmospheric reactions of polycyclic aromatic hydrocarbons: facile formation of mutagenic nitro derivatives. , 1978, Science.
[7] M. J. Coon,et al. Reductive beta-scission of the hydroperoxides of fatty acids and xenobiotics: role of alcohol-inducible cytochrome P-450. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[8] D. Koop. Oxidative and reductive metabolism by cytochrome P450 2E1 , 1992, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[9] T. Slater,et al. Cytochrome P-450 distribution in rat liver and the effect of sodium phenobarbitone administration. , 1978, Chemico-biological interactions.
[10] F. Guengerich,et al. Estimation of isozymes of microsomal cytochrome P-450 in rats, rabbits, and humans using immunochemical staining coupled with sodium dodecyl sulfate-polyacrylamide gel electrophoresis. , 1982, Biochemistry.
[11] S. Wolff,et al. Activity of nitro-polynuclear aromatic hydrocarbons in the sister chromatid exchange assay with and without metabolic activation. , 1982, Environmental mutagenesis.
[12] E. Smuckler,et al. Alterations of specific forms of cytochrome P-450 in rat liver during acute carbon tetrachloride intoxication. , 1981, Toxicology and applied pharmacology.
[13] M. Ingelman-Sundberg,et al. Cytochrome P-450-dependent formation of reactive oxygen radicals: isozyme-specific inhibition of P-450-mediated reduction of oxygen and carbon tetrachloride. , 1990, Xenobiotica; the fate of foreign compounds in biological systems.
[14] S. Chatterjee,et al. Membrane lipid peroxidation and its pathological consequences. , 1988, Indian journal of biochemistry & biophysics.
[15] M. Ingelman-Sundberg,et al. Hydroxyl-radical production and ethanol oxidation by liver microsomes isolated from ethanol-treated rats. , 1986, The Biochemical journal.
[16] W. G. Levine. Metabolism of azo dyes: implication for detoxication and activation. , 1991, Drug metabolism reviews.
[17] M. Ingelman-Sundberg,et al. Mechanisms of hydroxyl radical formation and ethanol oxidation by ethanol-inducible and other forms of rabbit liver microsomal cytochromes P-450. , 1984, The Journal of biological chemistry.
[18] I. Roots,et al. Possible control of hydrogen peroxide production and degradation in microsomes during mixed function oxidation reaction. , 1973, Biochemical and biophysical research communications.
[19] W. G. Levine,et al. Studies on the mechanism of reduction of azo dye carcinogens by rat liver microsomal cytochrome P-450. , 1989, Chemico-biological interactions.
[20] R. Raag,et al. Cytochrome P450cam: crystallography, oxygen activation, and electron transfer1 , 1992, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[21] A. Goldblum,et al. Quantum chemical studies of anaerobic reductive metabolism of halothane by cytochrome P-450. , 1980, Chemico-biological interactions.
[22] E. Jeffery,et al. Interaction of constitutive and phenobarbital-induced cytochrome P-450 isozymes during the sequential oxidation of benzphetamine. Explanation for the difference in benzphetamine-induced hydrogen peroxide production and 455-nm complex formation in microsomes from untreated and phenobarbital-treated r , 1983, Molecular pharmacology.
[23] C. Cerniglia,et al. The reduction of azo dyes by the intestinal microflora. , 1992, Critical reviews in microbiology.
[24] H. Strobel,et al. Identification and characterization of an NADPH-cytochrome P450 reductase derived peptide involved in binding to cytochrome P450. , 1991, Archives of biochemistry and biophysics.
[25] E. Mimnaugh,et al. A possible role for membrane lipid peroxidation in anthracycline nephrotoxicity. , 1986, Biochemical pharmacology.
[26] T. Iyanagi,et al. Interaction between NADPH-cytochrome P-450 reductase and cytochrome P-450 in the membrane of phosphatidylcholine vesicles. , 1979, Biochimica et biophysica acta.
[27] Nico P. E. Vermeulen,et al. A preliminary 3D model for cytochrome P450 2D6 constructed by homology model building , 1993, J. Comput. Aided Mol. Des..
[28] T. Poulos,et al. High-resolution crystal structure of cytochrome P450cam. , 1987, Journal of molecular biology.
[29] L. Weiner,et al. Redox transformations of quinone antitumor drugs in liver microsomes , 1988, FEBS letters.
[30] H. Rouach,et al. Implication of free radical mechanisms in ethanol-induced cellular injury. , 1992, Free radical biology & medicine.
[31] P. Souček,et al. Cytochromes P-450 in rats: structures, functions, properties and relevant human forms. , 1992, Xenobiotica; the fate of foreign compounds in biological systems.
[32] H. Kuthan,et al. Oxidase and oxygenase function of the microsomal cytochrome P450 monooxygenase system. , 1982, European journal of biochemistry.
[33] M. Klingenberg. Pigments of rat liver microsomes. , 1958, Archives of biochemistry and biophysics.
[34] W. G. Levine,et al. Two classes of azo dye reductase activity associated with rat liver microsomal cytochrome P-450. , 1991, Advances in experimental medicine and biology.
[35] J. Malone,et al. (+)- and (–)-Benzo[a]pyrene 7,8-oxide : synthesis, absolute stereochemistry, and stereochemical correlation with other mammalian metabolites of benzo[a]pyrene , 1980 .
[36] J. Thompson,et al. Reductive metabolism of 1,1,1,2-tetrachloroethane and related chloroethanes by rat liver microsomes. , 1984, Chemico-biological interactions.
[37] P. O'Brien,et al. Molecular mechanisms for bromotrichloromethane cytotoxicity in isolated rat hepatocytes. , 1990, Xenobiotica; the fate of foreign compounds in biological systems.
[38] D. Jerina,et al. Metabolism of chrysene and phenanthrene to bay-region diol epoxides by rat liver enzymes. , 1981, Molecular pharmacology.
[39] D. Macphee,et al. Crystal violet: a direct-acting frameshift mutagen whose mutagenicity is enhanced by mammalian metabolism. , 1984, Mutation research.
[40] R. C. Garner,et al. Nitrated polycyclic aromatic hydrocarbons: potent bacterial mutagens and stimulators of DNA repair synthesis in cultured human cells. , 1981, Carcinogenesis.
[41] N. Vermeulen,et al. One-electron reductive bioactivation of 2,3,5,6-tetramethylbenzoquinone by cytochrome P450. , 1992, Biochemical pharmacology.
[42] C. S. Yang,et al. The association between cytochrome P‐450 and NADPH‐cytochrome P‐450 reductase in microsomal membrane , 1975, FEBS letters.
[43] J. Castro,et al. Reductive metabolism and activation of benznidazole. , 1984, Biochemical pharmacology.
[44] P. O'Brien. Molecular mechanisms of quinone cytotoxicity. , 1991, Chemico-biological interactions.
[45] I. Phillips,et al. Quantification of NADPH: cytochrome P-450 reductase in liver microsomes by a specific radioimmunoassay technique. , 1983, The Biochemical journal.
[46] D. J. Reed,et al. Involvement of FMN and phenobarbital cytochrome P-450 in stimulating a one-electron reductive denitrosation of 1-(2-chloroethyl)-3-(cyclohexyl)-1-nitrosourea catalyzed by NADPH-cytochrome P-450 reductase. , 1983, The Journal of biological chemistry.
[47] R. Mason,et al. Two sites of azo reduction in the monooxygenase system. , 1988, Molecular pharmacology.
[48] C. N. Martin,et al. Rat liver microsomal azoreductase activity on four azo dyes derived from benzidine, 3,3'-dimethylbenzidine or 3,3'-dimethoxybenzidine. , 1981, Carcinogenesis.
[49] R. Estabrook,et al. Oxycytochrome P-450: its breakdown to superoxide for the formation of hydrogen peroxide. , 1979, Acta biologica et medica Germanica.
[50] F. Guengerich,et al. Purification of cytochrome P-450, NADPH-cytochrome P-450 reductase, and epoxide hydratase from a single preparation of rat liver microsomes. , 1980, Archives of biochemistry and biophysics.
[51] W. D. Hewson,et al. 6 – Peroxidases, Catalases, and Chloroperoxidase , 1979 .
[52] L. Koymans,et al. Cytochromes P450: their active-site structure and mechanism of oxidation. , 1993, Drug metabolism reviews.
[53] W. S. Brinigar,et al. Solvent effects on reversible formation and oxidative stability of heme-oxygen complexes. , 1974, Journal of the American Chemical Society.
[54] M. Terada,et al. Mutagenicity of nitropyrenes in Chinese hamster V79 cells. , 1983, Gan.
[55] Formation of superoxide ion via one-electron transfer from electron donors to singlet oxygen , 1983 .
[56] D. Nebert,et al. Evolution of the P450 gene superfamily: animal-plant 'warfare', molecular drive and human genetic differences in drug oxidation. , 1990, Trends in genetics : TIG.
[57] S. Sligar,et al. Spin state control of the hepatic cytochrome P450 redox potential. , 1979, Biochemical and biophysical research communications.
[58] Mark T. Fisher,et al. Control of heme protein redox potential and reduction rate: linear free energy relation between potential and ferric spin state equilibrium , 1985 .
[59] T. Lampidis,et al. Mitochondrial and plasma membrane potentials cause unusual accumulation and retention of rhodamine 123 by human breast adenocarcinoma-derived MCF-7 cells. , 1985, The Journal of biological chemistry.
[60] Duane F. Bruley,et al. Oxygen transport to tissue , 1973 .
[61] C. Ioannides,et al. Molecular orbital studies of oxygen activation and mechanisms of cytochromes P-450-mediated oxidative metabolism of xenobiotics. , 1989, Chemico-biological interactions.
[62] R. Estabrook,et al. ACTIVE OXYGEN—FACT OR FANCY , 1977 .
[63] C. Cerniglia,et al. Biotransformation of gentian violet to leucogentian violet by human, rat, and chicken intestinal microflora. , 1984, Drug metabolism and disposition: the biological fate of chemicals.
[64] N. Harada,et al. Participation of cytochrome P-450 in the reduction of nitro compounds by rat liver microsomes. , 1980, Journal of biochemistry.
[65] E. Testai,et al. Biochemical alterations elicited in rat liver microsomes by oxidation and reduction products of chloroform metabolism. , 1986, Chemico-biological interactions.
[66] B C Finzel,et al. Crystal structure of substrate-free Pseudomonas putida cytochrome P-450. , 1986, Biochemistry.
[67] S. Sligar,et al. Kinetics of cytochrome P-450 reduction: evidence for faster reduction of the high-spin ferric state. , 1985, Biochemistry.
[68] Guengerich Fp. Oxidation-reduction properties of rat liver cytochromes P-450 and NADPH-cytochrome P-450 reductase related to catalysis in reconstituted systems , 1983 .
[69] A. Y. Lu,et al. Studies on the association of cytochrome P-450 and NADPH-cytochrome c reductase during catalysis in a reconstituted hydroxylating system. , 1979, The Journal of biological chemistry.
[70] J. Schenkman,et al. The cytochrome P450 2B4-NADPH cytochrome P450 reductase electron transfer complex is not formed by charge-pairing. , 1992, The Journal of biological chemistry.
[71] R. Estabrook,et al. Cytochrome P-450—Its Role in Oxygen Activation for Drug Metabolism , 1977 .
[72] I. Fridovich,et al. Superoxide dismutase: the first twenty years (1968-1988). , 1988, Free radical biology & medicine.
[73] S A van Acker,et al. A predictive model for substrates of cytochrome P450-debrisoquine (2D6). , 1992, Chemical research in toxicology.
[74] D. Gustafson,et al. Role of xanthine oxidase in the potentiation of doxorubicin-induced cardiotoxicity by mitomycin C. , 1991, Cancer communications.
[75] A. Bast. Is formation of reactive oxygen by cytochrome P-450 perilous and predictable? , 1986 .
[76] M. J. Coon,et al. Oxygen activation by cytochrome P-450. , 1980, Annual review of biochemistry.
[77] John T. Groves,et al. Reactive iron porphyrin derivatives related to the catalytic cycles of cytochrome P-450 and peroxidase. Studies of the mechanism of oxygen activation , 1988 .
[78] A. Benson,et al. Biochemical determinants of Adriamycin toxicity in mouse liver, heart and intestine. , 1992, Biochemical pharmacology.
[79] W. Backes,et al. Cytochrome P-450 LM2 reduction. Substrate effects on the rate of reductase-LM2 association. , 1989, The Journal of biological chemistry.
[80] D. Jerina,et al. Absolute configuration of the trans-9,10-dihydrodiol metabolite of the carcinogen benzo[a]pyrene , 1982 .
[81] N. Vermeulen,et al. Role of hepatic microsomal and purified cytochrome P-450 in one-electron reduction of two quinone imines and concomitant reduction of molecular oxygen. , 1987, Biochemical pharmacology.
[82] C. Chiang,et al. Evidence for the stability and cytochrome P450 specificity of the phenobarbital-induced reductive halothane-cytochrome P450 complex formed in rat hepatic microsomes. , 1991, Biochemical pharmacology.
[83] M. Manno,et al. Suicidal inactivation of human cytochrome P-450 by carbon tetrachloride and halothane in vitro. , 1992, Pharmacology & toxicology.
[84] W. Levin,et al. Studies on the induction of CO-binding pigments in liver microsomes by phenobarbital and 3-methylcholanthrene. , 1967, Biochemical and biophysical research communications.
[85] D. Jerina,et al. Chemical modification and inactivation of rat liver microsomal cytochrome P-450c by 2-bromo-4'-nitroacetophenone. , 1986, The Journal of biological chemistry.
[86] D. Jerina,et al. Mechanism of inactivation of rat liver microsomal cytochrome P-450c by 2-bromo-4'-nitroacetophenone. , 1986, The Journal of biological chemistry.
[87] S. Shibata,et al. Reduction of 2,4-dinitrotoluene by Wistar rat liver microsomal and cytosol fractions. , 1984, Toxicology and applied pharmacology.
[88] J. Doroshow. Role of hydrogen peroxide and hydroxyl radical formation in the killing of Ehrlich tumor cells by anticancer quinones. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[89] H. Taniguchi,et al. Role of the electron transfer system in microsomal drug monooxygenase reaction catalyzed by cytochrome P-450. , 1984, Archives of biochemistry and biophysics.
[90] V. Ullrich,et al. Uncoupling of monooxygenation and electron transport by fluorocarbons in liver microsomes. , 1971, European journal of biochemistry.
[91] B. Zielińska,et al. A Possible formation pathway for the 2-nitrofluoranthene observed in ambient particulate organic matter , 1986 .
[92] S. Nesnow,et al. Inhibition of benzo(A)pyrene monooxygenase by α-naphthoflavone may be partially mediated by the metabolite9-hydroxy-α-naphthoflavone , 1982 .
[93] W. Nastainczyk,et al. Effect of oxygen concentration on the reaction of halothane with cytochrome P450 in liver microsomes and isolated perfused rat liver. , 1978, Biochemical Pharmacology.
[94] Association of hydrophobic substances with hemin. Characterization of the reverse type I binding spectrum and its relationship to cytochrome P-450. , 1986, Biochemical pharmacology.
[95] T. Iyanagi,et al. Rate-limiting step in the reconstituted microsomal drug hydroxylase system. , 1977, Journal of biochemistry.
[96] J. Gillette,et al. Mechanism of p-nitrobenzoate reduction in liver: the possible role oc cytochrome P-450 in liver microsomes. , 1968, Molecular pharmacology.
[97] P. R. Montellano. Cytochrome P-450 , 1986, Springer US.
[98] N. Bachur,et al. NADPH cytochrome P-450 reductase activation of quinone anticancer agents to free radicals. , 1979, Proceedings of the National Academy of Sciences of the United States of America.
[99] S. Sligar,et al. Cytochrome P-450cam and Other Bacterial P-450 Enzymes , 1986 .
[100] K. Danenberg,et al. NAD(P)H:quinone oxidoreductase gene expression in human colon carcinoma cells: characterization of a mutation which modulates DT-diaphorase activity and mitomycin sensitivity. , 1992, Cancer research.
[101] M. Ingelman-Sundberg,et al. Ligand-dependent maintenance of ethanol-inducible cytochrome P-450 in primary rat hepatocyte cell cultures. , 1988, Biochemical and biophysical research communications.
[102] H. Rosenkranz,et al. The extraordinary mutagenicity of nitropyrenes in bacteria. , 1981, Mutation research.
[103] G. Powis. Free radical formation by antitumor quinones. , 1989, Free radical biology & medicine.
[104] A. Y. Lu,et al. Electroimmunochemical quantitation of cytochrome P-450, cytochrome P-448, and epoxide hydrolase in rat liver microsomes. , 1981, The Journal of biological chemistry.
[105] M. Ingelman-Sundberg,et al. Carbon tetrachloride‐induced lipid peroxidation dependent on an ethanol‐inducible form of rabbit liver microsomal cytochrome P‐450 , 1985, FEBS letters.
[106] D. T. Sawyer,et al. On the chemical reactivity of superoxide ion , 1978 .
[107] M. D. Corbett,et al. Metabolism of 4-Chloronitrobenzene by the Yeast Rhodosporidium sp , 1981, Applied and environmental microbiology.
[108] A. Stoppani,et al. Inhibition of microsomal lipid peroxidation and cytochrome P-450-catalyzed reactions by nitrofuran compounds. , 1991, Free radical research communications.
[109] A. Elgoyhen,et al. Serotonin uptake inhibitors and the prejunctional effects of serotonin on peripheral sympathetic nerves. , 1986, Life sciences.
[110] S. Sligar,et al. Metabolic switching in cytochrome P-450cam: Deuterium isotope effects on regiospecificity and the monooxygenase/oxidase ratio , 1987 .
[111] S. Kitamura,et al. Azoreductase activity of liver aldehyde oxidase. , 1983, Chemical & pharmaceutical bulletin.
[112] S. Martinis,et al. Crystal structure of the cytochrome P-450CAM active site mutant Thr252Ala. , 1991, Biochemistry.
[113] W. G. Levine,et al. Role of electronic factors in binding and reduction of azo dyes by hepatic microsomes. , 1992, The Journal of pharmacology and experimental therapeutics.
[114] A. Stier. TRIFLUOROACETIC ACID AS METABOLITE OF HALOTHANE. , 1964, Biochemical pharmacology.
[115] Seiki Mukai,et al. Volatile Metabolites of Halothane in the Rabbit , 1977, Anesthesiology.
[116] C. Auclair,et al. Superoxide anion production by liver microsomes from phenobarbital treated rat. , 1978, Biochemical pharmacology.
[117] H. Strobel,et al. Isolation of the membrane-binding peptide of NADPH-cytochrome P-450 reductase. Characterization of the peptide and its role in the interaction of reductase with cytochrome P-450. , 1981, The Journal of biological chemistry.
[118] V. Ullrich,et al. Metabolism and cytochrome P-450 binding spectra of (+)- and (-)-hexobarbital in rat liver microsomes. , 1969, Hoppe-Seyler's Zeitschrift fur physiologische Chemie.
[119] M. J. Coon,et al. Spectral intermediates in the reaction of oxygen with purified liver microsomal cytochrome P-450. , 1976, Biochemical and biophysical research communications.
[120] W. G. Levine,et al. Azoreduction of N,N-dimethyl-4-aminoazobenzene (DAB) by rat hepatic microsomes. Selective induction by clofibrate. , 1986, Drug Metabolism And Disposition.
[121] M. J. Coon,et al. Structural features of liver microsomal NADPH-cytochrome P-450 reductase. Hydrophobic domain, hydrophilic domain, and connecting region. , 1982, The Journal of biological chemistry.
[122] O. Strubelt. Alcohol Potentiation of Liver Injury , 1984 .
[123] M. Harms-Ringdahl,et al. Nuclear membrane lipid peroxidation products bind to nuclear macromolecules. , 1989, Archives of biochemistry and biophysics.
[124] B. Testa,et al. Inhibitors of Cytochrome P-450s and their mechanism of action. , 1981, Drug metabolism reviews.
[125] N. Vermeulen,et al. Disposition of hexobarbital: 15 years of an intriguing model substrate. , 1988, Drug metabolism reviews.
[126] J. Lipscomb,et al. The role of putidaredoxin and P450 cam in methylene hydroxylation. , 1972, The Journal of biological chemistry.
[127] R. V. Van dyke,et al. The formation of chlorobenzene and benzene by the reductive metabolism of lindane in rat liver microsomes. , 1985, Archives of biochemistry and biophysics.
[128] J. Schenkman,et al. Status of the cytochrome P-450 cycle , 1981 .
[129] J. R. Brown,et al. Involvement of hydroxyl radical formation and DNA strand breakage in the cytotoxicity of anthraquinone antitumour agents. , 1990, Free radical research communications.
[130] R. Mason,et al. Spin-trapping and direct electron spin resonance investigations of the redox metabolism of quinone anticancer drugs. , 1980, Biochimica et biophysica acta.
[131] R. Estabrook,et al. Spectral studies of drug interaction with hepatic microsomal cytochrome. , 1967, Molecular pharmacology.
[132] R. O. Recknagel,et al. Evaluation of a role for phosgene production in the hepatotoxic mechanism of action of carbon tetrachloride and bromotrichloromethane. , 1982, Toxicology and applied pharmacology.
[133] B. James,et al. One-electron electrochemical reduction of a ferrous porphyrin dioxygen complex , 1981 .
[134] T. Slater,et al. The metabolism of halothane by hepatocytes: a comparison between free radical spin trapping and lipid peroxidation in relation to cell damage. , 1983, Chemico-biological interactions.
[135] B. Sinha. Free radicals in anticancer drug pharmacology. , 1989, Chemico-biological interactions.
[136] F. Guengerich. Cytochrome P450: advances and prospects , 1992, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[137] M. Ingelman-Sundberg,et al. Rat liver microsomal NADPH-supported oxidase activity and lipid peroxidation dependent on ethanol-inducible cytochrome P-450 (P-450IIE1). , 1989, Biochemical pharmacology.
[138] J. Farber,et al. Mechanisms of cell injury with hepatotoxic chemicals. , 1984, Pharmacological reviews.
[139] W. Koppenol,et al. The kinetics of the reduction of cytochrome c by the superoxide anion radical. , 1976, Biochimica et biophysica acta.
[140] S. D. Black,et al. Membrane topology of mammalian cytochromes P-450 from liver endoplasmic reticulum. Determination by trypsinolysis of phenobarbital-treated microsomes. , 1989, The Journal of biological chemistry.
[141] R. Mason,et al. Microsomal reduction of gentian violet. Evidence for cytochrome P-450-catalyzed free radical formation. , 1982, Molecular pharmacology.
[142] L. J. King,et al. The degradation of haem by carbon tetrachloride: metabolic activation requires a free axial coordination site on the haem iron and electron donation. , 1989, Xenobiotica; the fate of foreign compounds in biological systems.
[143] M. Ingelman-Sundberg,et al. Effect of in vivo chromate, acetone and combined treatment on rat liver in vitro microsomal chromium(VI) reductive activity and on cytochrome P450 expression. , 1991, Pharmacology & toxicology.
[144] S. D. Black. Membrane topology of the mammalian P450 cytochromes , 1992, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[145] G. Powis,et al. Metabolism and reactions of quinoid anticancer agents. , 1987, Pharmacology & therapeutics.
[146] E. Frolova,et al. Hydroxyl radical generation and DNA strand scission mediated by natural anticancer and synthetic quinones , 1989, FEBS letters.
[147] R. Mason,et al. Microsomal reduction of 3-amino-1,2,4-benzotriazine 1,4-dioxide to a free radical. , 1991, Molecular pharmacology.
[148] J. Gutteridge. Iron promoters of the Fenton reaction and lipid peroxidation can be released from haemoglobin by peroxides , 1986, FEBS letters.
[149] N. Vermeulen,et al. Cytochrome P450 2B1-mediated one-electron reduction of adriamycin: a study with rat liver microsomes and purified enzymes. , 1993, Molecular pharmacology.
[150] M. Rogawski,et al. Selectivity in the inhibition of mammalian cytochromes P-450 by chemical agents. , 1990, Pharmacological reviews.
[151] W. L. Weller,et al. Metabolic Fate of Hexobarbital (HBj , 1972 .
[152] R. Mason,et al. Inhibition of azoreductase by oxygen. The role of the azo anion free radical metabolite in the reduction of oxygen to superoxide. , 1978, Molecular pharmacology.
[153] W. G. Levine,et al. A novel application of cyclic voltammetry for direct investigation of metabolic intermediates in microsomal azo reduction. , 1991, Chemical research in toxicology.
[154] N. Vermeulen,et al. Reductase and oxidase activity of rat liver cytochrome P450 with 2,3,5,6-tetramethylbenzoquinone as substrate. , 1992, Chemico-biological interactions.
[155] S. Sligar,et al. Metabolic activation of mitomycin C by liver microsomes and nuclei. , 1982, Biochemical pharmacology.
[156] S. Kitamura,et al. Reductive metabolism of aromatic nitro compounds including carcinogens by rabbit liver preparations. , 1986, Cancer research.
[157] R. Ebel,et al. Temperature dependence of cytochrome P-450 reduction. A model for NADPH-cytochrome P-450 reductase:cytochrome P-450 interaction. , 1976, The Journal of biological chemistry.
[158] T. Takano,et al. Interaction of 1,1,1-trichloroethane with the mixed-function oxidation system in rat liver microsomes. , 1988, Xenobiotica; the fate of foreign compounds in biological systems.
[159] T. Tsong,et al. Rapid conformational changes of cytochrome P-450: effect of dimyristoyl lecithin. , 1978, Proceedings of the National Academy of Sciences of the United States of America.
[160] S. Sligar,et al. Oxygenase-catalyzed biological hydroxylations. , 1975, Annual review of biochemistry.
[161] A. Y. Lu,et al. Rat liver cytosolic azoreductase. Electron transport properties and the mechanism of dicumarol inhibition of the purified enzyme. , 1979, The Journal of biological chemistry.
[162] W. Backes,et al. Relationship between the rate of reductase-cytochrome P450 complex formation and the rate of first electron transfer. , 1992, Archives of biochemistry and biophysics.
[163] B. Zielińska,et al. The mutagenicity of 2-nitrofluoranthene and its in vitro hepatic metabolites. , 1987, Mutation research.
[164] N. Vermeulen,et al. One-electron reduction of mitomycin c by rat liver: role of cytochrome P-450 and NADPH-cytochrome P-450 reductase. , 1990, Xenobiotica; the fate of foreign compounds in biological systems.
[165] R. Mason,et al. In vivo radical trapping and biliary secretion of radical adducts of carbon tetrachloride-derived free radical metabolites. , 1988, Drug metabolism and disposition: the biological fate of chemicals.
[166] M. J. Coon,et al. On the stoichiometry of the oxidase and monooxygenase reactions catalyzed by liver microsomal cytochrome P-450. Products of oxygen reduction. , 1984, The Journal of biological chemistry.
[167] N. D'souza,et al. Hepatic antioxidant enzymes and lipid peroxidation in carbon tetrachloride-induced liver cirrhosis in rats. , 1988, Biochemical medicine and metabolic biology.
[168] R. Raag,et al. Crystal structure of the carbon monoxide-substrate-cytochrome P-450CAM ternary complex. , 1989, Biochemistry.
[169] T. Noll,et al. The crucial role of low steady state oxygen partial pressures in haloalkane free-radical-mediated lipid peroxidation. Possible implications in haloalkane liver injury. , 1986, Biochemical pharmacology.
[170] P. O'Brien,et al. Hydroperoxide catalyzed liver microsomal aromatic hydroxylation reactions involving cytochrome P-450. , 1974, Biochemical and biophysical research communications.
[171] D. Nelson,et al. On the membrane topology of vertebrate cytochrome P-450 proteins. , 1988, The Journal of biological chemistry.
[172] G. Powis,et al. Pulse radiolysis studies of antitumor quinones: radical lifetimes, reactivity with oxygen, and one-electron reduction potentials. , 1981, Archives of biochemistry and biophysics.
[173] M. Ingelman-Sundberg,et al. Human liver microsomal cytochrome P-450IIE1. Immunological evaluation of its contribution to microsomal ethanol oxidation, carbon tetrachloride reduction and NADPH oxidase activity. , 1989, Biochemical pharmacology.
[174] S. Moreno,et al. Metabolism and mode of action of gentian violet. , 1988, Memorias do Instituto Oswaldo Cruz.
[175] B. Puschendorf,et al. Effects of the lipidperoxidation product 4-hydroxynonenal and related aldehydes on proliferation and viability of cultured Ehrlich ascites tumor cells. , 1985, Biochemical pharmacology.
[176] M. J. Coon,et al. Identification of the high and low potential flavins of liver microsomal NADPH-cytochrome P-450 reductase. , 1978, The Journal of biological chemistry.
[177] M. Kawahara,et al. Halothane‐induced hepatic microsomal lipid peroxidation in guinea pigs and rats , 1989, Journal of applied toxicology : JAT.
[178] M. J. Coon,et al. The P450 superfamily: updated listing of all genes and recommended nomenclature for the chromosomal loci. , 1989, DNA.
[179] L. Weiner,et al. Microsomal and photochemical oxidation and reduction of 1-piperidinoanthraquinone. , 1982, Biochimica et biophysica acta.
[180] M. Ingelman-Sundberg,et al. Mechanisms of lipid peroxidation dependent upon cytochrome P-450 LM2. , 1986, European journal of biochemistry.
[181] D. Jerina,et al. Stereoselectivity of rat liver cytochrome P-450c on formation of benzo[a]pyrene 4,5-oxide. , 1981, Biochemical and biophysical research communications.
[182] M. J. Coon,et al. Role of a hydrophobic polypeptide in the N-terminal region of NADPH-cytochrome P-450 reductase in complex formation with P-450LM. , 1979, Biochemical and biophysical research communications.
[183] P. McCay,et al. Specificity of a phenobarbital-induced cytochrome P-450 for metabolism of carbon tetrachloride to the trichloromethyl radical. , 1982, Biochemical pharmacology.
[184] A. Bast,et al. Inhibition of mono-oxygenase and oxidase activity of rat-hepatic cytochrome P-450 by H2-receptor blockers. , 1984, Xenobiotica; the fate of foreign compounds in biological systems.
[185] D. Jerina,et al. Stereoselective formation of benz[a]anthracene (+)-(5S,6R)-oxide and (+)-(8R,9S)-oxide by a highly purified and reconstituted system containing cytochrome P-450c. , 1982, Biochemical and biophysical research communications.
[186] F. Kadlubar,et al. Microsomal-catalyzed hydroperoxide-dependent C-oxidation of amines. , 1973, Biochemical and biophysical research communications.
[187] F. Gonzalez,et al. The induction of a specific form of cytochrome P-450 (P-450j) by fasting. , 1987, Biochemical and biophysical research communications.
[188] A. D. McLean,et al. Theoretical investigations of the anaerobic reduction of halogenated alkanes by cytochrome P 450. 1. Structures, inversion barriers, and heats of formation of halomethyl radicals , 1987 .
[189] H. Strobel,et al. Purified NADPH cytochrome P-450 reductase. Interaction with hepatic microsomes and phospholipid vesicles. , 1979, The Journal of biological chemistry.
[190] J. Castro,et al. Early destruction of cytochrome P-450 in testis of carbon tetrachloride poisoned rats. , 1978, Toxicology.
[191] T Shimizu,et al. Role of Glu318 at the putative distal site in the catalytic function of cytochrome P450d. , 1992, Biochemistry.
[192] M. Kessler,et al. Homeostasis of oxygen supply in liver and kidney. , 1973, Advances in experimental medicine and biology.
[193] T. Kamataki,et al. Participation of cytochrome P-450 in reductive metabolism of 1-nitropyrene by rat liver microsomes. , 1984, Cancer research.
[194] T. Omura,et al. THE CARBON MONOXIDE-BINDING PIGMENT OF LIVER MICROSOMES. I. EVIDENCE FOR ITS HEMOPROTEIN NATURE. , 1964, The Journal of biological chemistry.
[195] P. O'Brien,et al. Toxicity of nitrobenzene compounds towards isolated hepatocytes: dependence on reduction potential. , 1990, Xenobiotica; the fate of foreign compounds in biological systems.
[196] S. Sligar,et al. Kinetics of hepatic cytochrome P-450 reduction: correlation with spin state of the ferric heme. , 1982, Biochemistry.
[197] W. G. Levine,et al. Mechanism of azoreduction of dimethylaminoazobenzene by rat liver NADPH-cytochrome P-450 reductase and partially purified cytochrome P-450. Oxygen and carbon monoxide sensitivity and stimulation by FAD and FMN. , 1988, Drug metabolism and disposition: the biological fate of chemicals.
[198] H. de Groot,et al. Self-catalysed, O2-independent inactivation of NADPH- or dithionite-reduced microsomal cytochrome P-450 by carbon tetrachloride. , 1981, Biochemical pharmacology.
[199] T. Tanaka,et al. Superoxide anion is the initial product in the hydrogen peroxide formation catalyzed by NADPH oxidase in porcine thyroid plasma membrane. , 1989, The Journal of biological chemistry.
[200] G. Powis,et al. Relationship of the single-electron reduction potential of quinones to their reduction by flavoproteins. , 1980, Biochemical pharmacology.
[201] R. Estabrook,et al. On the inhibitory action of mersalyl on microsomal drug oxidation: a rigid organization of the electron transport chain. , 1971, Archives of biochemistry and biophysics.
[202] J. Gillette,et al. Studies on the mechanism of action of mammalian hepatic azoreductase. II. The effects of phenobarbital and 3-methylcholanthrene on carbon monoxide sensitive and insensitive azoreductase activities. , 1967, Biochemical pharmacology.
[203] S. Kawato,et al. Rotation of cytochrome P-450. Complex formation of cytochrome P-450 with NADPH-cytochrome P-450 reductase in liposomes demonstrated by combining protein rotation with antibody-induced cross-linking. , 1983, The Journal of biological chemistry.
[204] W. G. Levine,et al. Multiple mechanisms in hepatic microsomal azoreduction. , 1992, Xenobiotica; the fate of foreign compounds in biological systems.
[205] C. Villee,et al. Early role during chemical evolution for cytochrome P450 in oxygen detoxification , 1975, Nature.
[206] J. H. van Lenthe,et al. A theoretical study on the metabolic activation of paracetamol by cytochrome P-450: indications for a uniform oxidation mechanism. , 1988, Chemical research in toxicology.
[207] S. Sligar,et al. Reduction kinetics of purified rat liver cytochrome P-450. Evidence for a sequential reaction mechanism dependent on the hemoprotein spin state. , 1984, Biochemistry.
[208] H. Griffiths,et al. Reactive oxygen species induce antigenic changes in DNA , 1989, FEBS letters.
[209] A. Y. Lu,et al. The Topology of the Mammalian Cytochrome P-450 Active Site , 1986 .